Nanotechnology-Driven Strategy Against Viral Infections
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 23
Special Issue Editor
Interests: viruses; nanotechnology; drug delivery; nanoparticles; nanoemulsions; liposomes; neglected diseases; cancer treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viral infections continue to pose global health challenges, as evidenced by pandemics such as HIV, HPV, herpes, influenza, respiratory viruses and COVID-19. Traditional therapies using classical antiviral drugs often face limitations including resistance, poor targeting, and systemic toxicity. Nanotechnology offers innovative solutions for preventing, diagnosing, and treating viral diseases, predominately through drug delivery using nanocarriers such as nanoparticles (polymeric, lipid, metallic, ceramic, mesoporous silica, and composite), liposomes, nanoemulsions, dendrimers, and quantum dots. In addition to classic antiviral delivery systems, other therapies are available, such as gene silencing strategies, immunomodulation, nanovaccines, photodynamic therapy, and combination therapies. Nanocarriers are capable of transporting and sustaining the release of classical antivirals, improving the bioavailability of active compounds and reducing adverse effects. Other active compounds can be encapsulated in nanocarriers, such as vaccine antigens, interfering RNA (siRNA), and photosensitizers for photodynamic therapy. Metallic nanoparticles of copper, silver, zinc oxide, and gold can additionally be used to combat viruses. Furthermore, nanocarriers can be administered topically for the treatment of skin and mucosal viruses or into the bloodstream to induce systemic effects. Nanotechnology is revolutionizing the development of antiviral strategies for therapy, diagnosis, and prevention. Some challenges, however, still prevail, particularly in scaling up production; sufficient quantities of nanomaterials, following the Good Practices guidelines established by regulatory agencies, are needed to support clinical studies.
Prof. Dr. Eduardo Ricci-Júnior
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- antivirals
- drug delivery
- nanoparticles
- liposomes
- dendrimers
- vaccines
- SiRNA
- photodynamic therapy
- immunomodulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
